On February 11, Aba Chemicals Corporation(300261) continued to fall sharply at the opening. As of the noon closing, the share price fell 12.33%.
Since the resumption of trading this week, Aba Chemicals Corporation(300261) share price has continued to decline, with a cumulative decline of more than 40%, and the market value has shrunk by more than 10 billion yuan. With covid-19 oral drug speculation stalled and various funds scrambled to flee, the once four times bull stocks became one of the worst stocks in the year of the tiger.
resumption of trading fell by more than 40%
On the morning of February 11, Aba Chemicals Corporation(300261) continued to fall sharply. As of the morning closing, Aba Chemicals Corporation(300261) reported 15.43 yuan per share, down 12.33%, with the latest market value of 14.86 billion yuan.
On February 6, Aba Chemicals Corporation(300261) announced that the company had checked the matters related to the abnormal fluctuation of stock trading, the relevant self-examination had been completed, and the trading of the company’s shares resumed from the opening of the market on February 7.
Since then, Aba Chemicals Corporation(300261) has started the sharp decline mode. It fell to the limit on the day of resumption, and hit the limit again the next day. Finally, it fell by 17.66%, and the two-day decline was 34.11%. As of Friday morning trading, Aba Chemicals Corporation(300261) had fallen nearly 44% from the previous high of 27.32 yuan per share, and its market value had shrunk by more than 11.4 billion yuan.
Before that, Aba Chemicals Corporation(300261) had a very eye-catching performance. According to the data of CSI Taurus, due to the concept of covid-19 oral medicine, from November 1, 2021 to January 14, 2022, Aba Chemicals Corporation(300261) share price started to run all the way from around 5 yuan. During this period, it continuously harvested 20cm limit, with a cumulative increase of 432.55%, becoming one of the most brilliant bull stocks in the A-share market at that time. Because of the continuous abnormal fluctuation of the stock price, Aba Chemicals Corporation(300261) was suspended urgently twice, and received the attention letter from the exchange for many times, which was questioned as a hot spot.
The data show that the dynamic P / E ratio before Aba Chemicals Corporation(300261) suspension reached 130.93 times, far exceeding the industry average. So far, Aba Chemicals Corporation(300261) dynamic P / E ratio has fallen to 73.95 times.
covid-19 oral drug hype flameout
In terms of sectors, covid-19 detection sectors fell collectively in early trading, Andon Health Co.Ltd(002432) fell 6.31%, and individual stocks such as Shanghai Zj Bio-Tech Co.Ltd(688317) , Shenzhen Bioeasy Biotechnology Co.Ltd(300942) and Asahi biology fell one after another.
On the news side, Andon Health Co.Ltd(002432) announced on the evening of February 10 that in the teleconference surveyed by the organization, in view of the company’s operation in the United States, Andon Health Co.Ltd(002432) said that at present, the number of new cases in the United States has decreased compared with before, and the tension between supply and demand of covid-19 test kit products has eased.
The reporter noted that compared with the previous sharp rise in share prices, investors recently asked a lot less questions about Kalon anhydride products on the interactive platform. The attention to Aba Chemicals Corporation(300261) in the stock bar has also decreased significantly. Some investors said that the market speculation has ended, and more investors directly cut meat and admit losses.
the announcement caliber of carbonic anhydride products has been adjusted
It is worth noting that for the relevant statements of carbonic anhydride products concerned by the market, the caliber in the Aba Chemicals Corporation(300261) resumption announcement is also different from the previous caliber. This minor adjustment has been concerned by some media and investors.
Source: company announcement
In the announcement of resumption of trading, Aba Chemicals Corporation(300261) said that the carbonic anhydride and its derivatives refer to compounds, not specifically the products produced by the company. It is impossible to determine that the carbonic anhydride and its derivatives produced by the company can be used to synthesize Pfizer covid-19 oral medicine.
As for the business relationship with Pfizer, Aba Chemicals Corporation(300261) once again said that the company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, and has not supplied carlon anhydride products to Pfizer.
In addition, for the production expansion plan of carbonic anhydride concerned by the market, Aba Chemicals Corporation(300261) announced that the company is studying the production expansion of carbonic anhydride and its derivatives, but it has not yet decided whether to expand the production, and there is still great uncertainty about whether to expand the production in the end. When the downstream market situation of carbonic anhydride and its derivatives becomes clear, the company will make planning and prudent decision on whether to expand production.
